Jorge A. Garcia, MD, FACP
Advertisement
Articles by Jorge A. Garcia, MD, FACP
Jorge Garcia, MD, FACP, provides insight on the case of a 69-year-old man with mCRPC and assesses the classes of agents currently available as treatment options.
Advertisement
Latest Updated Articles
Management of mCRPC: Radium-223May 19th 2020
Radium 223: Counseling Patients With mCRPCMay 19th 2020
Case Overview: 69-Year-Old Man With Advanced CRPCMay 19th 2020
Approaching Therapy for mCRPCMay 19th 2020
Standard of Care for mCRPCMay 19th 2020
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Improving Survival, Quality of Life, and Cost-Effectiveness for Allo-HCT
2
FDA Panel Votes 10-3 In Favor of RP1 Plus Nivolumab for Advanced Melanoma
3
NCCN Lists Gedatolisib Regimens as Preferred Option in HR+/HER2– Metastatic Breast Cancer
4
FDA Approves Lutetium Lu 177 Vipivotide Tetraxetan Plus ARPI in mAPMN/S Prostate Cancer
5